Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYO1B | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
mRNA | PITX2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
mRNA | GOT2 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
mRNA | ZCWPW1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
mRNA | ATP5J2-PTCD1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
mRNA | SBK2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | BID | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | USMG5 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | TMEM9 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
mRNA | RPP14 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |